John Reid (pharmacologist)
John Reid (1940-2019) was a renowned pharmacologist and biochemist known for his significant contributions to the field of pharmacology. His research primarily focused on the molecular mechanisms of drug action, particularly in relation to neurotransmitters and neuropharmacology.
Early Life and Education[edit | edit source]
John Reid was born in 1940 in Scotland. He developed an interest in science at a young age, which led him to pursue a degree in biochemistry from the University of Edinburgh. After completing his undergraduate studies, Reid continued his education at the same university, earning a PhD in pharmacology.
Career[edit | edit source]
Reid began his career as a research scientist at the University of Cambridge, where he worked on understanding the molecular mechanisms of drug action. His work in this area led to significant advancements in the field of pharmacology, particularly in the understanding of how drugs interact with receptors in the body.
In 1975, Reid moved to the University of Glasgow, where he continued his research in pharmacology. He was particularly interested in the role of neurotransmitters in drug action, and his work in this area contributed to the development of new treatments for neurological disorders.
Contributions to Pharmacology[edit | edit source]
Reid's research has had a significant impact on the field of pharmacology. His work on the molecular mechanisms of drug action has helped to improve our understanding of how drugs interact with the body, leading to the development of more effective treatments for a range of conditions.
One of Reid's most significant contributions was his research on neurotransmitters. He was one of the first scientists to demonstrate that neurotransmitters play a crucial role in drug action, a discovery that has had a profound impact on the field of neuropharmacology.
Death and Legacy[edit | edit source]
John Reid passed away in 2019, leaving behind a significant legacy in the field of pharmacology. His research has had a lasting impact on our understanding of drug action, and his contributions to the field continue to influence current research in pharmacology and neuropharmacology.
See Also[edit | edit source]
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
